|9.42||+0.2200||+2.39%||Vol 233||1Y Perf -31.34%|
|Oct 4th, 2023 15:31 DELAYED|
|- -||- -%|
|Target Price||22.00||Analyst Rating||— 0.00|
|Potential %||133.55||Finscreener Ranking||★★★ — -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★+ — -|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★ — -|
|Price Range Ratio 52W %||24.42||Earnings Rating||Buy|
|Market Cap||39.53M||Earnings Date||28th Mar 2012|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||2.21K|
|Avg. Monthly Volume||1.78K|
|Avg. Quarterly Volume||3.14K|
Daxor Corporation (AMEX: DXR) stock closed at 9.42 per share at the end of the most recent trading day (a 2.39% change compared to the prior day closing price) with a volume of 233.0000 shares and market capitalization of 39.53M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 750 people. Daxor Corporation CEO is Michael Feldschuh.
The one-year performance of Daxor Corporation stock is -31.34%, while year-to-date (YTD) performance is 2.84%. DXR stock has a five-year performance of 54.43%. Its 52-week range is between 7.81 and 14.4041, which gives DXR stock a 52-week price range ratio of 24.42%
Daxor Corporation currently has a PE ratio of 8.60, a price-to-book (PB) ratio of 2.03, a price-to-sale (PS) ratio of -28.75, a price to cashflow ratio of 26.90, a PEG ratio of -, a ROA of 24.14%, a ROC of -% and a ROE of 27.66%. The company’s profit margin is 79.30%, its EBITDA margin is -%, and its revenue ttm is $-1 396 490.00 , which makes it $-0.33 revenue per share.
Of the last four earnings reports from Daxor Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Daxor Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Daxor Corporation is — (0), with a target price of $22, which is +133.55% compared to the current price. The earnings rating for Daxor Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Daxor Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Daxor Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 31.99, ATR14 : 0.29, CCI20 : -173.53, Chaikin Money Flow : -0.21, MACD : -0.09, Money Flow Index : 37.61, ROC : -3.66, RSI : 42.81, STOCH (14,3) : 21.52, STOCH RSI : 0.30, UO : 36.63, Williams %R : -78.48), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Daxor Corporation in the last 12-months were: Feldschuh Michael (Buy at a value of $19 500), Goudie Joy (Buy at a value of $2 925)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.